title: Chronic Administration of Monosodium Glutamate under Chronic Variable Stress Impaired Hypothalamic-Pituitary-Adrenal Axis Function in Rats.
abstract: The hypothalamic-pituitary-adrenal (HPA) axis is the primary endocrine system to respond to stress. The HPA axis may be affected by increased level of corticotrophin-releasing factors under chronic stress and by chronic administration of monosodium glutamate (MSG). The purpose of this study was to investigate whether chronic MSG administration aggravates chronic variable stress (CVS)-induced behavioral and hormonal changes. Twenty-four adult male Sprague-Dawley rats, weighing 200~220 g, were divided into 4 groups as follows: water administration (CON), MSG (3 g/kg) administration (MSG), CVS, and CVS with MSG (3 g/kg) administration (CVS+MSG). In addition, for the purpose of comparing the effect on plasma corticosterone levels between chronic stress and daily care or acute stress, 2 groups were added at the end of the experiment; the 2 new groups were as follows: naïve mice (n=7) and mice exposed to restraint stress for 2 h just before decapitation (A-Str, n=7). In an open field test performed after the experiment, the CVS+MSG group significant decrease in activity. The increase in relative adrenal weights in the CVS and CVS+MSG group was significantly greater than those in the CON and/or MSG groups. In spite of the increase in the relative adrenal weight, there was a significant decrease in the plasma corticosterone levels in the CVS+MSG group as compared to all other groups, except the naïve group. These results suggest that impaired HPA axis function as well as the decrease in the behavioral activity in adult rats can be induced by chronic MSG administration under CVS rather than CVS alone.
authors.affiliation: Department of Physiology and Digestive Disease Research Institute, School of Medicine, Wonkwang University, Iksan 570-749, Korea.
authors.forename: Hee Jeong
authors.initials: HJ
authors.lastname: Seo
authors.forename: Hyang-Do
authors.initials: HD
authors.lastname: Ham
authors.forename: Hyung Yong
authors.initials: HY
authors.lastname: Jin
authors.forename: Woo Hyung
authors.initials: WH
authors.lastname: Lee
authors.forename: Hyun Sub
authors.initials: HS
authors.lastname: Hwang
authors.forename: Soon-Ah
authors.initials: SA
authors.lastname: Park
authors.forename: Yong Sung
authors.initials: YS
authors.lastname: Kim
authors.forename: Suck Chei
authors.initials: SC
authors.lastname: Choi
authors.forename: Seoul
authors.initials: S
authors.lastname: Lee
authors.forename: Kyung Jae
authors.initials: KJ
authors.lastname: Oh
authors.forename: Byung Sook
authors.initials: BS
authors.lastname: Kim
authors.forename: Byung Rim
authors.initials: BR
authors.lastname: Park
authors.forename: Moon Young
authors.initials: MY
authors.lastname: Lee
references.citation: J Psychiatr Res. 1999 May-Jun;33(3):181-214
references.pmid: 10367986
references.citation: Endocr Res. 2000 Nov;26(4):537-44
references.pmid: 11196426
references.citation: Eur J Pharmacol. 2000 Jun 30;399(1):43-7
references.pmid: 10876021
references.citation: J Endocrinol. 1994 Jun;141(3):497-503
references.pmid: 8071649
references.citation: Behav Brain Res. 2008 Jan 10;186(1):32-40
references.pmid: 17716752
references.citation: Behav Brain Res. 2005 Jun 3;161(1):45-59
references.pmid: 15904709
references.citation: Nutrition. 2005 Jun;21(6):749-55
references.pmid: 15925301
references.citation: Ann N Y Acad Sci. 1997 Jun 21;821:57-75
references.pmid: 9238194
references.citation: Behav Pharmacol. 1999 Feb;10(1):73-83
references.pmid: 10780304
references.citation: Brain Res Bull. 1986 Sep;17(3):285-9
references.pmid: 3490298
references.citation: Neurobehav Toxicol Teratol. 1984 Mar-Apr;6(2):171-5
references.pmid: 6472563
references.citation: Physiol Behav. 1994 Nov;56(5):861-7
references.pmid: 7824585
references.citation: Curr Pharm Des. 2005;11(8):963-72
references.pmid: 15777247
references.citation: J Gastroenterol Hepatol. 2008 Dec;23(12):1840-6
references.pmid: 18752563
references.citation: Physiol Behav. 1994 Apr;55(4):747-53
references.pmid: 8190805
references.citation: Psychoneuroendocrinology. 2000 Jan;25(1):1-35
references.pmid: 10633533
references.citation: Brain Res. 2005 Jan 21;1031(2):185-93
references.pmid: 15649443
references.citation: Brain Res Bull. 2008 Sep 5;77(1):8-12
references.pmid: 18579108
references.citation: Neurosci Lett. 1995 Jun 23;193(1):45-8
references.pmid: 7566663
references.citation: Am J Psychiatry. 2003 Sep;160(9):1554-65
references.pmid: 12944327
references.citation: Neuroendocrinology. 1988 Aug;48(2):105-11
references.pmid: 2851747
references.citation: J Pharmacol Exp Ther. 2002 Apr;301(1):333-45
references.pmid: 11907191
references.citation: Neurotoxicol Teratol. 2005 May-Jun;27(3):465-73
references.pmid: 15939206
references.citation: Neuroreport. 1999 Aug 20;10(12):2551-6
references.pmid: 10574368
references.citation: J Nutr. 2000 Apr;130(4S Suppl):1049S-52S
references.pmid: 10736380
references.citation: Brain Res. 1986 Sep 24;382(2):416-21
references.pmid: 3756525
references.citation: Biol Psychiatry. 1990 May 15;27(10):1094-102
references.pmid: 2340320
references.citation: Prog Neurobiol. 1996 Apr;48(6):569-612
references.pmid: 8809909
references.citation: CNS Spectr. 2001 Jul;6(7):555-6, 561-4
references.pmid: 15573019
references.citation: J Neurosci Res. 2006 Feb 15;83(3):497-507
references.pmid: 16416425
references.citation: Neuroendocrinology. 1993 Jan;57(1):70-8
references.pmid: 8097578
references.citation: Physiol Behav. 2007 Jan 30;90(1):29-35
references.pmid: 17023009
references.citation: Psychoneuroendocrinology. 2001 Jul;26(5):443-59
references.pmid: 11337130
references.citation: Eur J Clin Nutr. 2007 Mar;61(3):304-13
references.pmid: 16957679
references.citation: Neuroreport. 1995 Dec 15;6(18):2450-2
references.pmid: 8741739
references.citation: Brain Res. 1996 Oct 14;736(1-2):76-81
references.pmid: 8930311
references.citation: J Endocrinol. 1999 Jan;160(1):1-12
references.pmid: 9854171
references.citation: Neuroendocrinology. 1995 Oct;62(4):326-32
references.pmid: 8544945
references.citation: Neuroendocrinology. 1975;18(2):213-6
references.pmid: 170555
references.citation: Psychopharmacology (Berl). 2004 Oct;176(1):30-8
references.pmid: 15071721
references.citation: Endocrinol Metab Clin North Am. 2001 Sep;30(3):695-728; vii-viii
references.pmid: 11571937
references.citation: Neurosci Lett. 2008 Mar 5;433(1):59-64
references.pmid: 18248896
references.citation: Physiol Behav. 2003 Apr;78(4-5):703-10
references.pmid: 12782226
references.citation: AMA Arch Ophthalmol. 1957 Aug;58(2):193-201
references.pmid: 13443577
references.citation: Biol Psychiatry. 1999 Nov 1;46(9):1167-80
references.pmid: 10560023